Can finasteride or dutasteride cause gynecomastia?

Haircafe
15 Feb 202119:48

Summary

TLDRThe video script discusses the use of finasteride as a treatment for male pattern baldness, addressing concerns over its potential side effects, particularly gynecomastia. It clarifies the difference between actual gynecomastia and pseudogynecomastia, reviews the incidence rates from clinical trials, and dispels myths about the drug's side effects. The speaker advocates for a balanced view, suggesting that the benefits of finasteride often outweigh the rare risks, and offers advice for those who may不幸地, experience side effects.

Takeaways

  • πŸ’Š Finasteride is a medication that has been used since 1992 to treat male pattern baldness by inhibiting the conversion of testosterone to dihydrotestosterone (DHT).
  • πŸ‘€ Millions of men have benefited from finasteride with a very small, acceptable risk of side effects, which can often be mitigated through dosage adjustments.
  • πŸ“‰ The fear of prolonged side effects from finasteride is unfounded as these have not been medically verified, and side effects typically resolve with discontinuation of the drug.
  • πŸ€” The perception of baldness as a cosmetic defect can negatively impact self-esteem, but finasteride offers a solution to hair loss concerns.
  • πŸŽ₯ A video from a British dating show illustrates the societal impact of hair loss, where initial impressions can be heavily influenced by a person's hair or lack thereof.
  • 🚫 The script discourages the idea that shaving one's head as a solution to baldness will result in an appealing look, suggesting it may not be as universally flattering as some believe.
  • πŸ€·β€β™‚οΈ It emphasizes that even attractive bald men could potentially look better with a full head of hair, highlighting the aesthetic value of hair in framing a face.
  • πŸ”¬ The script delves into the medical aspects of finasteride, explaining its mechanism of action and its impact on hormone levels, particularly testosterone and estrogen.
  • 🀰 The concern of gynecomastia (male breast tissue development) as a side effect of finasteride is addressed, distinguishing between actual gynecomastia and pseudogynecomastia (fat distribution).
  • πŸ“Š Clinical data is presented to show that the incidence of gynecomastia from finasteride is very low, especially when compared to the benefits of hair loss prevention.
  • ⚠️ The rarity of gynecomastia as a side effect is underscored, with the script suggesting that the fear surrounding it is disproportionate to the actual risk.

Q & A

  • What is the primary purpose of finasteride as discussed in the script?

    -The primary purpose of finasteride, as discussed in the script, is to treat male pattern baldness by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), which is responsible for hair loss.

  • Why might some people be hesitant to take finasteride according to the script?

    -Some people might be hesitant to take finasteride due to fear of side effects, such as prolonged side effects or gynecomastia, despite these being medically unverified or statistically rare.

  • What is the script's stance on the belief that finasteride side effects can be prolonged?

    -The script refutes the belief that finasteride side effects can be prolonged, stating that this idea has never been medically verified.

  • What is the difference between actual gynecomastia and pseudogynecomastia as mentioned in the script?

    -Actual gynecomastia involves the development of breast tissue in men, while pseudogynecomastia is simply fat distribution to the chest area that can be resolved by weight loss or liposuction.

  • How does the script address the concern of developing gynecomastia from finasteride?

    -The script addresses the concern by explaining the mechanism behind finasteride and the actual incidence rates from clinical trials, emphasizing that the risk is extremely low and often reversible.

  • What does the script suggest about the impact of hair loss on first impressions?

    -The script suggests that hair loss, particularly when resulting in a shaved ring of hair, can leave a negative first impression, potentially leading to dismissal by others.

  • According to the script, what is the incidence rate of gynecomastia with the use of 5 milligrams of finasteride daily?

    -The incidence rate of gynecomastia with the use of 5 milligrams of finasteride daily is reported to be only 0.3 percent in the largest study involving over 14,000 patients.

  • What alternative treatments are mentioned in the script for individuals who develop gynecomastia from finasteride?

    -The script mentions prescription aromatase inhibitors like Arimidex or Letrozole, and tamoxifen (Nolvadex) as alternative treatments, but also highlights the potential side effects and risks associated with these drugs.

  • What does the script suggest as a potential solution for individuals who cannot tolerate the side effects of finasteride?

    -The script suggests that for individuals who cannot tolerate the side effects of finasteride, surgery (gynecomastia surgery) might be a safer and more definitive solution than trying to counteract the side effects with other drugs.

  • How does the script characterize the fear and paranoia surrounding finasteride's side effects?

    -The script characterizes the fear and paranoia surrounding finasteride's side effects as being out of proportion to the reality of the situation, emphasizing that the actual incidence of side effects is very low.

  • What advice does the script give regarding the use of finasteride and the fear of side effects?

    -The script advises that if the fear of side effects like gynecomastia is too great, individuals should consider the potential consequences of not taking finasteride, such as the impact of hair loss on their appearance and self-esteem.

Outlines

00:00

πŸ’Š Finasteride: The Solution to Male Pattern Baldness

This paragraph discusses the use of finasteride as a medication for treating male pattern baldness. It highlights the drug's effectiveness since its introduction in 1992 and addresses common misconceptions about its side effects. The speaker emphasizes that finasteride's side effects are rare, mild, and often temporary, and that fears about prolonged effects are unfounded. The paragraph also touches on societal perceptions of baldness and the importance of hair in physical attractiveness, using a British dating show example to illustrate the point. It concludes by encouraging men to consider finasteride to avoid the negative impacts of hair loss.

05:01

πŸ€” Debunking Finasteride Hysteria and Gynecomastia Concerns

The speaker delves into the hysteria surrounding finasteride, particularly the fear of developing gynecomastia, or male breast tissue. They clarify the difference between actual gynecomastia and pseudogynecomastia, which is fat distribution. The paragraph explains the mechanism of finasteride, its impact on hormone levels, and the extremely low incidence of gynecomastia associated with its use. The speaker cites studies and statistics to show that the risk of gynecomastia from finasteride is minimal, even at higher doses, and that most reported cases are based on anecdotal evidence rather than clinical trials.

10:02

πŸ“Š Analyzing the Incidence of Gynecomastia with Finasteride Use

This paragraph presents a detailed analysis of the incidence of gynecomastia in patients using finasteride, comparing it with another drug, dutasteride. The speaker reviews various studies, including a large one with over 14,000 patients, which reported a gynecomastia incidence of only 0.3 percent. They also discuss case reports of gynecomastia with finasteride at the standard dosage for hair loss, noting that these are rare and often resolve after treatment cessation. The paragraph emphasizes that the risk of gynecomastia is low and that fear of this side effect is disproportionate to the actual data.

15:02

πŸ›‘ Addressing Gynecomastia and Finasteride: Solutions and Perspective

The final paragraph addresses what to do if someone develops gynecomastia from finasteride, suggesting titration adjustments and the possibility of using prescription medications like aromatase inhibitors or tamoxifen. The speaker also mentions over-the-counter supplements, though they note the lack of proven effectiveness. They propose surgery as a definitive solution for gynecomastia. The paragraph concludes by urging individuals not to let fear of a rare side effect deter them from using finasteride, reminding them of the potential social consequences of hair loss and suggesting that surgery for gynecomastia is a more affordable and permanent solution than other hair restoration methods.

Mindmap

Keywords

πŸ’‘Finasteride

Finasteride is a medication primarily used to treat male pattern baldness by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), which is responsible for hair loss in men. In the video's context, it is presented as a simple pill that has been a solution for many men's hair loss problems since 1992. The script discusses the benefits and side effects of finasteride, emphasizing its effectiveness and the rarity of side effects.

πŸ’‘Male Pattern Baldness

Male pattern baldness, also known as androgenetic alopecia, is a common type of hair loss in men where hair thins and falls out in a characteristic pattern. The script uses this term to describe the condition that finasteride is intended to treat, highlighting the impact of hair loss on men's self-esteem and the importance of finding a solution like finasteride.

πŸ’‘Side Effects

In the context of the video, side effects refer to the potential negative impacts or unintended consequences of taking finasteride. The script mentions that while side effects are rare and often mild, they are a point of concern for some men considering the medication. It also addresses the fear-mongering around prolonged side effects, which the script argues are not medically verified.

πŸ’‘Gynecomastia

Gynecomastia is a condition in which male breast tissue develops. The video discusses this as a potential, albeit rare, side effect of finasteride. It differentiates between actual gynecomastia and pseudogynecomastia (fat distribution in the chest area) and provides data on the incidence of gynecomastia in patients taking finasteride, emphasizing its rarity.

πŸ’‘Titration

Titration in the context of medication refers to adjusting the dosage to achieve the desired effect while minimizing side effects. The script suggests that finasteride's effectiveness can be maintained at less than the standard dosage, implying that titration could be a strategy to mitigate potential side effects.

πŸ’‘DHT (Dihydrotestosterone)

Dihydrotestosterone is a hormone that is a more potent androgen than testosterone and is considered the primary culprit for male pattern baldness. The script explains that finasteride works by suppressing the conversion of testosterone into DHT, thus helping to prevent hair loss.

πŸ’‘Aromatase Pathway

The aromatase pathway is the process by which testosterone is converted into estrogen in the body. The script mentions this pathway to explain how finasteride, by reducing the conversion of testosterone to DHT, may lead to an increase in testosterone levels and subsequently a small increase in estrogen levels, which could potentially cause side effects like gynecomastia.

πŸ’‘Nocebo Effect

The nocebo effect refers to the phenomenon where a person experiences negative side effects after being told that a treatment may cause them, even if the treatment is inert or not causing the side effects. The script warns against the nocebo effect, suggesting that fear and misinformation about finasteride could lead to individuals experiencing side effects due to their expectations rather than the medication itself.

πŸ’‘Aromatase Inhibitors

Aromatase inhibitors are a class of drugs that reduce the amount of estrogen in the body by inhibiting the aromatase enzyme. The script briefly mentions these as a potential treatment for gynecomastia caused by finasteride, although it also notes the cardiovascular risks associated with their use.

πŸ’‘Tamoxifen

Tamoxifen, also known as Nolvadex, is a selective estrogen receptor modulator (SERM) that can be used to treat certain types of breast cancer and gynecomastia. The script mentions tamoxifen as a possible treatment for gynecomastia caused by finasteride, but also notes its side effects, including hair loss.

πŸ’‘Gynosurgery

Gynosurgery refers to surgical procedures to correct gynecomastia. The script suggests this as a potential solution for individuals who develop gynecomastia as a side effect of finasteride and for whom other treatments are not effective or desirable.

Highlights

Finasteride, introduced in 1992, has been a solution for male pattern baldness, offering millions of men a simple pill to combat hair loss.

For many years, finasteride was taken with minimal side effects, and even those could be mitigated through dosage adjustments.

Finasteride's side effects are generally rare, mild, and reversible upon discontinuation, contrary to common misconceptions.

The fear-mongering around prolonged side effects of finasteride is medically unverified, yet it persists among some individuals.

The societal and dating implications of baldness are highlighted, suggesting that a full head of hair is often perceived more favorably.

Gynecomastia, or male breast tissue development, is a rare side effect of finasteride, often confused with pseudogynecomastia, which is related to fat distribution.

The mechanism of finasteride involves suppressing the 5Ξ±-reductase enzyme, leading to less dihydrotestosterone (DHT) and potentially more testosterone converted to estrogen.

Clinical trials and post-marketing surveillance indicate a very low incidence of gynecomastia associated with finasteride use.

Dutasteride, another hair loss treatment, may have a higher incidence of gynecomastia compared to finasteride, suggesting the latter as a safer option.

Case reports of gynecomastia from finasteride are rare and often involve younger men, suggesting a link with higher baseline testosterone levels.

Gynecomastia caused by finasteride is typically reversible upon stopping the medication, with most cases resolving within 10 months.

The fear and paranoia around finasteride's side effects are disproportionate to the actual risks, as evidenced by the lack of a significant increase in reported cases.

There is no predictive test to determine who might be more susceptible to gynecomastia from finasteride, making it a concern for some.

Adjusting the dosage of finasteride or using prescription aromatase inhibitors may help mitigate the risk of gynecomastia.

Surgery is presented as a potential solution for those who develop gynecomastia from finasteride, offering a permanent fix.

The transcript emphasizes the importance of not letting fear of rare side effects deter the use of finasteride, which has helped many combat hair loss.

Transcripts

play00:01

what's up chooms hope everybody had a

play00:03

prime valentine's day this weekend with

play00:06

your missus who picked

play00:07

you to be your significant other largely

play00:09

in part because you decided to join team

play00:11

finasteride

play00:12

instead of team slaphead 100 years ago

play00:15

who could have imagined that a cosmetic

play00:17

defect as

play00:18

horridly aesthetically unappealing as

play00:20

male pattern baldness

play00:21

could be solved by just taking a simple

play00:23

pill like finasteride

play00:25

since 1992 when finasteride first hit

play00:27

the market

play00:28

millions of men have had their minds put

play00:30

at ease knowing that they can solve all

play00:32

their hair loss problems

play00:33

by just taking finasteride for many

play00:36

years there were no

play00:37

issues with this drug at all people

play00:39

would take it knowingly knowing that

play00:40

there was a very small

play00:41

yet acceptable risk of side effects and

play00:44

even if you did get side effects you

play00:45

could easily mitigate those risks

play00:47

through titration

play00:48

as a as it has been shown that

play00:50

finasteride is effective

play00:52

even at less than the standard dosage

play00:54

finasteride side effects

play00:55

as we all know at this point are rare

play00:57

mild and will often go away on their own

play00:59

with continued use

play01:01

and will always go away with

play01:02

discontinuation the idea that the side

play01:04

effects from finasteride can be

play01:06

prolonged has never been medically

play01:08

verified

play01:08

yet people still continue to fear monger

play01:11

because it helps them cope with being

play01:12

bald

play01:13

miserable slap heads who have given up

play01:15

on life and want to drag everybody else

play01:17

down with them because remember

play01:18

misery loves company slap heads will

play01:20

tell you things they

play01:21

know are not true like shaving your head

play01:23

will make you look like jason statham

play01:25

vin diesel or the rock

play01:26

when the reality is you'll probably end

play01:28

up looking more like that albino kid

play01:30

from the movie powder

play01:31

or like that guy from the wife's

play01:33

boyfriend meme and even if your

play01:35

aesthetics are

play01:36

top tier enough that you can look good

play01:37

despite being bald

play01:39

chances are you still will drop several

play01:41

points in the aesthetics department

play01:43

since no matter how good a face may look

play01:45

you need a good head of hair to frame a

play01:47

handsome face

play01:48

that is why even bald men who look good

play01:51

would still look

play01:52

better if they had a full head of hair

play01:54

and that is only in the best case

play01:56

scenarios

play01:56

for most people the results of losing

play01:58

your hair are catastrophic and

play02:01

life destroying i mean just take a look

play02:03

at this video from a british dating show

play02:05

and bring on the boys

play02:08

[Applause]

play02:21

[Music]

play02:28

welcome to the show sir take it away and

play02:31

give it your best shots

play02:32

hello lady my name is emmitt and i'm

play02:34

from roscommon hey

play02:39

girls that's anna from roscommon but

play02:41

tell us you turned on or turned off

play02:52

[Music]

play02:53

[Laughter]

play02:56

holy [Β __Β ] i don't want to be too mean

play02:58

because you know i've been down that

play02:59

path before i know how it feels but

play03:00

you know just looking at this guy you

play03:02

could tell he has other glaring problems

play03:04

as well such as being weak

play03:06

effeminate looking he's a manlet he's a

play03:08

new male but you'll notice all the

play03:09

initial criticism from the women

play03:11

was aimed at this main miss man's lack

play03:14

of hair

play03:16

shannon lights off for you as well i'm

play03:17

doing my best for you here it's just the

play03:19

hair

play03:20

the lack of i mean i'm sorry so as you

play03:23

can see it is hair

play03:24

or a lack of hair that leaves the first

play03:27

impression on those who meet

play03:28

and nothing leaves a worse impression

play03:30

than when someone sees per a person

play03:32

who has a shaved ring of hair that looks

play03:35

like a toilet seat around their head

play03:36

which is appropriate because in this day

play03:38

of age you have got to have [Β __Β ] for

play03:40

brains to let yourself go bald

play03:42

it doesn't matter what your other merits

play03:44

may be if you don't give a good first

play03:46

impression

play03:46

people may dismiss you outright and you

play03:48

leave a terrible first impression

play03:50

when you are bald so stop fearing

play03:53

finasteride and

play03:54

start fearing what will happen to you if

play03:57

you don't take finasteride

play03:58

so on that note let's talk about a

play04:00

common concern many have

play04:02

many men have before beginning

play04:04

finasteride and that is the development

play04:06

of gynecomastia

play04:07

aka male breast tissue so before i get

play04:10

into this i think it is important that i

play04:12

distinguish between

play04:13

actual gynecomastia and

play04:15

pseudogynecomastia

play04:16

actual gynecomastia involves the

play04:18

development of breast tissue in men

play04:20

whereas pseudogynecomastia is just fat

play04:22

distribution to the chest area

play04:24

and men who get that can solve it by

play04:26

simply losing weight or maybe getting a

play04:28

liposuction so

play04:30

real gynecomastia can happen to men

play04:32

regardless of their body composition

play04:33

composition as you often see

play04:35

in professional bodybuilders who get

play04:37

gynecomastia even though they're

play04:39

extremely

play04:40

lean you'll see some female breast

play04:41

tissue on them and often this is because

play04:43

they use supraphysiological levels of

play04:45

testosterone which can then aromatize

play04:47

into estrogen

play04:48

and even though this is an extreme

play04:50

example of how gynecomastia can happen

play04:52

in men

play04:53

the mechanism behind finasteride

play04:55

possibly causing this side effect

play04:57

is similar even though as we'll see this

play04:59

is an extremely rare side effect of

play05:01

finasteride

play05:02

so the level of hysteria and concern

play05:04

people have over this

play05:05

is way overblown but nevertheless let's

play05:07

take a look at this

play05:08

balls deep as we always do so the

play05:10

mechanism behind finasteride is well

play05:12

understood at this point

play05:13

we know it suppresses the type 2 5a

play05:15

reductase pathway

play05:16

that converts testosterone into

play05:18

dihydrotestosterone which is the trash

play05:20

hormone that makes us go bald and does a

play05:22

whole bunch of other really horrible

play05:24

things

play05:24

um anyone who denies that dht is the

play05:26

primary culprit for hair loss and men

play05:28

genetically predisposed to male pattern

play05:29

baldness at this point

play05:30

is sprouting complete bro science at a

play05:32

level equivalent to what we see from the

play05:34

flat earth society

play05:36

or from anti-vaccination groups so as

play05:38

you can see in this figure

play05:40

testosterone can not only be converted

play05:42

to dht but also into estrogen via the

play05:45

aromatase pathway

play05:46

this seems counterintuitive at first but

play05:48

you have to understand

play05:49

men do in fact need some estrogen in

play05:51

their body for proper joint as well as

play05:53

proper cardiovascular health

play05:55

logically when you suppress the 5a

play05:57

reductase enzyme

play05:58

that will leave you with more overall

play06:00

testosterone and that is why finasteride

play06:02

will raise testosterone by 9 to 15

play06:05

or so in most people for most of us this

play06:07

isn't an issue at all

play06:08

and possibly this could even be

play06:10

beneficial and may explain why some

play06:12

people report things like higher libido

play06:14

while they take finasteride

play06:15

however some of this extra testosterone

play06:18

will be converted into a small

play06:20

amount of estrogen via the aromatase

play06:21

pathway so estrogen levels can rise

play06:24

slightly as well

play06:25

for most of us this is negligible and we

play06:27

won't even notice it

play06:28

but this could be why some people do get

play06:30

side effects from finasteride such as

play06:32

lower libido as well as gynecomastia

play06:34

so before anyone freaks out about this

play06:37

let's discuss the actual

play06:38

incidence of gynecomastia on finasteride

play06:41

how common is it really

play06:42

well if you look at the package insert

play06:44

for proscar which is the five milligram

play06:46

tablet of finasteride

play06:48

as opposed to propecia which is a one

play06:50

milligram tablet

play06:51

you can see that they looked not

play06:52

specifically at gynecomastia as a side

play06:54

effect

play06:55

but instead they looked at the incidence

play06:56

of breast enlargement and breast

play06:58

tenderness

play06:59

which are not necessarily equivalent to

play07:01

gynecomastia in any case

play07:02

they looked at about fifteen hundred

play07:04

patients on proscar versus fifteen

play07:06

hundred patients on placebo

play07:08

and saw the breast enlargement was seen

play07:09

in one point eight percent of patients

play07:11

on finasteride for up to four years

play07:13

versus one point one percent of patients

play07:15

on placebo

play07:16

the incidence of breast tenderness was

play07:18

up to 0.7 percent on finasteride and 0.3

play07:22

percent on placebo they also included

play07:24

data from another study

play07:25

of a total of about 1500 patients half

play07:28

on proscar and half on placebo

play07:30

and they concluded that the incidence of

play07:32

gynecomastia was 2.2 percent on proscar

play07:35

and 0.7 with placebo of course we

play07:38

are talking about proscar here not

play07:40

propecia propecia has the same active

play07:42

ingredient which is finasteride

play07:44

but only at one-fifth the dosage as a

play07:46

proscar tablet

play07:47

which has five milligrams of finasteride

play07:49

whereas again a propecia has just one

play07:51

milligram

play07:52

so what does the package insert for

play07:53

propecia actually say

play07:55

well we know it has to be rare because

play07:57

in the initial clinical trials which

play07:58

involved

play07:59

thousands of subjects there were no

play08:01

reported incidences of gynecomastia at

play08:04

all

play08:04

in fact the package insert reads quote

play08:07

in the clinical studies with propecia

play08:09

the incidences for breast tenderness and

play08:10

enlargement

play08:11

hypersensitivity reactions and

play08:13

testicular pain and finasteride treated

play08:14

patients

play08:15

were not different from those in

play08:17

patients treated with placebo unquote

play08:19

so in other words they didn't notice

play08:22

anything in any of the

play08:23

thousands of subjects initially studied

play08:24

and keep in mind this is an fda approved

play08:26

medication we're talking about here

play08:28

so the standards for approval are the

play08:30

most vigorous in the entire world

play08:32

and require hundreds of millions of

play08:33

dollars worth of research

play08:35

however based on the post-marketing case

play08:37

reports of gynecomastia from finasteride

play08:39

and because of the incidence of

play08:41

gynecomastia on proscar

play08:42

breast tenderness and enlargement were

play08:44

eventually added to the list of possible

play08:46

adverse reactions from taking propecia

play08:48

and that's why it's on the package

play08:50

insert today so reports of gynecomastia

play08:52

on low-dose finasteride are only based

play08:55

on crace reports which are the weakest

play08:57

form of

play08:57

evidence as we all know as they just

play08:59

involve one or two subjects so let's

play09:01

look at a paper describing two such case

play09:03

reports

play09:04

the first case report involved a 21 year

play09:06

old man with antridic alopecia

play09:08

who developed gynecomastia four months

play09:09

after starting treatment

play09:11

and he was on the standard dose of one

play09:12

milligram per day upon cessation

play09:15

the gyno did not resolve even after 10

play09:17

minutes off the drug

play09:18

now normally i'd say any reports of

play09:21

prolonged

play09:22

side effects from finasteride are

play09:23

completely bogus but in this case

play09:25

we're talking about tissue development

play09:27

so it is true that if you do get kind of

play09:29

hastily from finasteride

play09:30

you may need surgery to rectify this so

play09:33

this young man's case

play09:34

is rare but it's not completely

play09:36

implausible since you can't reverse

play09:38

tissue development without surgery in

play09:39

most cases so

play09:40

in the second case report this paper

play09:43

dealt with an older individual this time

play09:44

he was 65 years old

play09:46

and he had andronic alopecia it wasn't

play09:48

specified how severe it was but he

play09:50

but he developed gynecomastia after two

play09:52

months of treatment and his case was

play09:54

unilateral meaning only one breast was

play09:56

enlarged fortunately for him though the

play09:58

side effects did dissipate after two

play10:00

months off treatment

play10:01

but he still had some very slight

play10:03

swelling six years after stopping

play10:05

treatment

play10:05

and this was probably as a result of

play10:07

some press breast tissue development

play10:09

that never completely resolved

play10:10

even after he stopped taking the drug so

play10:12

he probably would need surgery as well

play10:14

so in this paper they also review the

play10:16

literature on gynecomastia with

play10:18

finasteride

play10:19

in table 1 you can see the incidence of

play10:21

gynecomastia in patients treated with 5

play10:23

milligrams per day of finasteride

play10:25

in the largest study involving over 14

play10:27

000 patients

play10:28

the reported incidence of gynecomastia

play10:30

was only 0.3 percent

play10:33

namely 42 out of 14 722 patients

play10:37

and you know i don't know about you guys

play10:39

but i think i take those odds especially

play10:40

when you're talking about proscar

play10:42

not propecia and keep in mind the

play10:43

standard dose of finasteride for

play10:44

treating male pattern baldness is only

play10:46

one-fifth

play10:47

of what was used in these studies and

play10:49

furthermore many people report success

play10:51

on even

play10:52

smaller doses another thing worth

play10:54

pointing out was that gynecomastia was

play10:56

listed as the third most common side

play10:58

effect in that study

play10:59

so they were accounting for all the

play11:00

other reported side effects from

play11:01

finasteride

play11:02

so if the third most common side effect

play11:04

for finasteride only affects 0.3 percent

play11:07

of patients

play11:08

that gives you an idea of just how rare

play11:10

side effects for finasteride are in

play11:11

general

play11:11

even at a dose of five milligrams per

play11:14

day which no men should be using for

play11:15

hair loss just one milligram or less per

play11:17

day is totally fine

play11:19

of the other studies in this table as

play11:21

you can see though the highest

play11:22

incidence was 4.5 percent in a study of

play11:25

9423 patients and the lowest was

play11:28

0 in a study of 70 patients but again

play11:31

in the largest study by far the

play11:33

incidence was only 0.3 percent

play11:36

they then show a table showing the

play11:37

incidence of gynecomastia from using

play11:39

dutasteride which is interesting

play11:41

dutasteride even though it isn't as well

play11:43

studied as finasteride for fighting hair

play11:45

loss

play11:45

especially long term is still known to

play11:47

suppress more dht than finasteride so it

play11:50

may possibly increase estrogen levels

play11:52

more

play11:53

since there will be even less

play11:54

testosterone being converted into dht

play11:56

and more converted by aromatase into

play11:59

estrogen compared to finasteride

play12:00

so if you look at the table you can see

play12:03

the studies have a

play12:04

similar but smaller sample size compared

play12:06

to the finasteride studies

play12:08

but they seem to show a higher incidence

play12:10

of gynecomastia

play12:11

with all the studies except for a small

play12:13

study involving 68 patients showing zero

play12:16

cases

play12:16

which could be a classic argument as to

play12:18

why having a large sample size is so

play12:21

important for these kind of studies

play12:22

the other studies however show an

play12:24

incidence of gynecomastia ranging from 1

play12:26

to

play12:26

2.3 percent which is still small but

play12:29

nevertheless many times as high as what

play12:31

the largest finasteride study showed

play12:33

so personally i think the risk of both

play12:35

these drugs are

play12:36

low enough to the point where you

play12:37

shouldn't be concerned but if you are

play12:39

really worried about gynecomastia it

play12:41

would probably be safer to use

play12:42

finasteride rather than dutasteride

play12:44

because even though

play12:44

the incidence of side effects is low

play12:46

with your testosterone it's many times

play12:48

lower with finasteride so

play12:49

both are low but finasteride's chances

play12:51

are even lower so

play12:52

anyways we've looked at finasteride at

play12:54

five milligrams as well as dutasteride

play12:56

at 0.5 milligrams

play12:58

but what about finasteride at one

play13:00

milligram daily as that is the standard

play13:02

dosage for angenic alopecia well

play13:04

in this table here you can see that all

play13:06

we have are case reports and no

play13:08

large clinical trials showing gyno as a

play13:10

side effect of propecia

play13:12

so interestingly all these case reports

play13:14

show that the gynecomastia was

play13:16

unilateral meaning again

play13:17

just one breast was getting gyno for

play13:19

some reason the age of

play13:21

onset in the subjects was mostly pretty

play13:23

early on with with most of them getting

play13:24

gyno as early as two to six months

play13:26

with one uh case of just one case of

play13:29

somebody getting it after 11 months

play13:31

so if you're already on finasteride and

play13:33

have been on it for like over a year

play13:34

let's say

play13:35

then the chances you'll get gyno seem to

play13:37

be pretty null fortunately for these

play13:38

subjects though it looks like most of

play13:40

their gyno resolved upon stopping

play13:42

treatment within

play13:43

at most 10 months or so the other thing

play13:45

to note is that the age of these

play13:46

patients was fairly young

play13:48

ranging from 18 to 29 years old with

play13:50

only one patient being on the older side

play13:52

at 53 years of age

play13:54

now this is speculative but i think this

play13:56

may have to do with younger men

play13:58

having higher baseline testosterone

play14:00

levels to begin with so if someone is

play14:01

really young and virile

play14:03

then it could be that the very small

play14:05

boost in testosterone they get from

play14:07

finasteride

play14:07

is enough for it to aromatize to a

play14:09

greater degree than if an older

play14:11

individual gets it since we know that

play14:12

testosterone drops a little bit as you

play14:14

get older

play14:14

again though i must go back to the first

play14:16

table and emphasize that gynecomastia

play14:18

was

play14:19

only reported and 0.3 percent of

play14:21

patients and a sample size of over

play14:23

14 000 patients on five milligrams of

play14:26

finasteride daily

play14:27

not one milligram so if you are a young

play14:30

man don't interpret this as a red flag

play14:32

to not use finasteride

play14:34

another way to look at this is that this

play14:36

is just a handful of case reports

play14:38

and we know that there are millions of

play14:40

people on finasteride for hair loss so

play14:42

again it seems the incidence of

play14:43

gynecomastia on one milligram of

play14:45

finasteride daily

play14:46

must be exceptionally low certainly

play14:48

nothing to panic over

play14:50

so as you can see from the available

play14:52

research

play14:53

gynecomastia like all of finasteride's

play14:55

reported side effects are dramatically

play14:57

overblown

play14:58

because people want to exaggerate their

play15:00

side effects because they're trying to

play15:01

sue

play15:01

merck however that being said i don't

play15:04

want to come across

play15:05

as being completely dismissive to the

play15:07

few people who do in fact get kind of

play15:09

gynecomastia as a result of taking

play15:11

finasteride but keep in mind there is no

play15:13

underlying predictor to find out whether

play15:15

or not certain people are more apt to

play15:16

get kynecomastia from finasteride

play15:18

compared to other people people can

play15:20

develop gynecomastia during puberty for

play15:22

instance but the endocrine system in an

play15:24

adolescent young man still undergoing

play15:26

development

play15:27

is not the same as an adult suppressing

play15:29

their dht through finasteride so just

play15:31

because you got gyno during puberty

play15:33

doesn't mean you're going to make it

play15:34

worse or get it again if you take

play15:36

finasteride

play15:37

there are a lot of shifts in the hormone

play15:39

and endocrine system

play15:40

levels during puberty before the

play15:41

hormones finally stabilize in adulthood

play15:44

so there are a whole plethora of factors

play15:45

that could cause kaino during

play15:47

adolescence that wouldn't apply to an

play15:49

adult taking finasteride

play15:50

also you don't need blood work before

play15:53

starting finasteride

play15:54

if you're already a healthy individual

play15:55

if you have some pre-existing

play15:57

endocrinological problem like

play15:58

hypogonadism

play16:00

or klein klinefelter syndrome then you

play16:02

might be at a greater risk but if that

play16:04

were the case you'd probably already

play16:05

have

play16:05

other symptoms in which case you should

play16:07

be speaking with an endocrinologist

play16:09

to get those problems resolved to begin

play16:10

with like going on trt

play16:12

people who are hypogenatal will almost

play16:14

always have symptoms

play16:16

and to screen everyone starting

play16:17

finasteride for hypogonadism would not

play16:19

be cost effective

play16:20

and basically would just be a big waste

play16:22

of time and money and if you're already

play16:24

so scared of getting gyno from

play16:25

finasteride

play16:26

that you feel that you need to get blood

play16:28

work even though we've already

play16:29

established it effects fewer than

play16:31

0.3 percent of users then chances are

play16:33

you're at a very high risk to give

play16:35

yourself a nocebo effect

play16:37

in which case you probably shouldn't use

play16:38

finasteride because the last thing we

play16:40

need in the hair loss community

play16:41

are more people spreading fear and

play16:43

misinformation about this drug there's

play16:44

plenty of that already

play16:45

so let's assume though the absolute

play16:49

worst case scenario has happened to you

play16:50

and you're one of the very few people

play16:52

who get gyno from finasteride

play16:54

so what can you do well the first most

play16:56

obvious thing you can do

play16:57

is adjust your titration finasteride

play17:00

standard dose is one milligram

play17:02

daily but it is common for doctors to

play17:04

prescribe less than that

play17:05

and at a lower frequency such as 0.5

play17:08

milligrams

play17:08

or 0.25 milligrams daily or every other

play17:11

day

play17:12

and patients still report success while

play17:14

potentially mitigating side effects

play17:16

being that five milligrams of

play17:18

finasteride only has a 0.3 percent

play17:20

chance of causing gyno

play17:22

then it seems like the chances on just a

play17:24

fraction of that would be

play17:26

very low unfathomably oh in fact but

play17:28

failing that

play17:29

what else can you do well there are

play17:32

prescription aromatase inhibitors you

play17:33

can use like arimidex or letrazole

play17:36

although these drugs aren't considered

play17:38

very cardiovascular friendly

play17:40

meaning they have the tendency to raise

play17:42

our cholesterol levels

play17:43

although keep in mind a doctor who would

play17:45

prescribe you an aromatase inhibitor for

play17:47

something like gyno

play17:48

would probably do so at an adjusted

play17:50

titration which might mitigate these

play17:52

risks

play17:53

although none of these drugs are

play17:54

completely risk-free another drug that

play17:57

could be prescribed would be something

play17:58

like tamoxifen

play18:00

which is also known as novodex which has

play18:02

a similar outcome but different

play18:04

mechanism

play18:04

as it is not an aromatase inhibitor but

play18:06

rather it is a serum not to be confused

play18:08

with sarms

play18:09

serum stands for selective estrogen

play18:12

receptor modulator

play18:13

which works as an estrogen receptor

play18:15

antagonist in the breast tissue

play18:17

unfortunately novadex isn't very side

play18:19

effect-friendly either

play18:20

and one of its reported side effects is

play18:22

even hair loss which kind of defeats the

play18:24

purpose of using finasteride to begin

play18:26

with

play18:27

so there are also numerous

play18:28

over-the-counter dietary supplements and

play18:30

purported natural aromatase inhibitors

play18:32

but none of these have been proven

play18:34

effective so if you are an individual

play18:36

who gets gynecomastia from finasteride

play18:38

i think the best solution would be to

play18:40

opt for something like

play18:42

surgery gynosurgery isn't super

play18:44

expensive

play18:45

and you can ask the doctor remove the

play18:46

gland altogether so that you'll never be

play18:48

at risk for gynecomastia ever again

play18:51

frankly i think that is a safer option

play18:53

than trying to counter one drug side

play18:55

effects

play18:56

with another drug especially something

play18:57

like tamoxifen or arimadex

play19:00

you know nobody wants to spend a few

play19:01

thousand dollars for a surgery but

play19:03

gynosurgery is still cheaper than a hair

play19:05

transplant

play19:05

so for some reason you can't get around

play19:07

the gynoside effects

play19:09

i think surgery is a good idea so

play19:10

anyways i don't think there really is

play19:12

anything more to talk about regarding

play19:14

this subject

play19:15

you know gyno from finasteride we know

play19:16

it's not common and the level of fear

play19:18

and paranoia

play19:19

people feel about this extremely rare

play19:21

side effect is

play19:22

way out of proportion to reality you

play19:24

know gyno is rare

play19:25

it is reversible with surgery and if the

play19:28

extremely low odds of getting gyno are

play19:30

still too great for you

play19:31

just remember what happened to this guy

play19:32

and ask yourself is that who i want to

play19:35

be

play19:35

nadine what happened he kind of looks a

play19:38

bit old and he's baldy like me da

play19:41

and no okay

play19:45

okay folks till next time take care

Rate This
β˜…
β˜…
β˜…
β˜…
β˜…

5.0 / 5 (0 votes)

Related Tags
FinasterideHair LossGynecomastiaMale Pattern BaldnessBaldness TreatmentDrug Side EffectsHealth ControversyMedical MythsAesthetic ConcernsMen's Health